BioMelbourne Network
Progressing BioIndustry
News and Opinions
2011
October
Melbourne Brain Centre Parkville enhances Victorias reputation for medical research
The Melbourne Brain Centre in Parkville will build on Victoria’s internationallyrenowned
reputation for leadership in medical research, Premier Ted Baillieu said
today.
Speaking at the opening of the Melbourne Brain Centre at Melbourne University’s
Parkville campus, Mr Baillieu said the new facility would strengthen connections
between researchers and clinicians, enhancing their ability ... read more…
Acrux Gets Marketing Authorisation For Recuvyra™
13 October 2011.
commercial use of Recuvyra 50 mg/mL transdermal solution for dogs. Recuvyra
contains the active ingredient fentanyl and is approved for the control of postoperative
pain associated with major orthopedic and soft tissue surgery in dogs. A
single dose applied to the skin of dogs prior to surgery controls pain for at least 4
days. The product was developed using a transde... read more…
Victorian Biotech People Appointed to R&D Tax Incentive Advisory Committee
Thursday, 13 October 2011. Experts from across small business and industry will oversee Australia’s new R&D Tax Incentive as it helps thousands of businesses invest in new ideas and products.
Announcing the new R&D Tax Incentive Advisory Committee, Innovation Minister Senator Kim Carr said it would mean that industry and business - users of the R&D tax Incentive – will be able to advise ... read more…
Innovation Australia Board Welcomes Three New Members
Thursday, 13 October 2011. Dr Nicholas Gruen, Mr Richard Shaddick and Mr Innes Willox have joined the board of Innovation Australia, the independent statutory body that provides expert advice and assists the Government with its innovation programs.
Innovation Minister Senator Kim Carr said the new appointees would strengthen the board, helping to increase innovation activity in Australian i... read more…
New China Agreements Advance Lead Drug Candidate and New Product Pipeline
13th October 2011. Melbourne. Agenix Limited (ASX: AGX) today confirmed it had signed two new agreements with its strategic partners in China covering the commercialisation of new drug candidates, the sharing of resources, expertise and completion of pre-clinical toxicology tests for its new hepatitis B drug in China.Agenix’s China subsidiary entered an agreement with China’s Institute of Pha... read more…
JDJ Bioservices and Charles River form local alliance
13 October 2011Australian biotechnology services and consultancy business, JDJ Bioservices, announced today that it had signed a distribution agreement with Charles River. JDJ Bioservices will be the Australian and New Zealand representative for Charles River Biopharmaceutical Services in the region.Charles River Biopharmaceutical Services (BPS) delivers client-focused solutions tailored ... read more…
$15 million for smart solutions to healthcare challenges
4 October 2011 - A new $15 million program to promote demand-driven innovation in Victoria’s healthcare system was today announced by Minister for Technology Gordon Rich-Phillips at a BioMelbourne Network event in Melbourne.
The Health Market Validation Program (Health MVP) is a competitive grants program that will leverage the power of government-as-customer to support the development of inno... read more…
Great Advances Expected From Centre For Neural Engineering
Tuesday, 4 October 2011. A better understanding of the human brain and diseases of the central nervous system is closer thanks to the new Centre for Neural Engineering at the University of Melbourne.
Established through a $17.5 million research infrastructure grant from round 2 of the Australian Government’s Education Investment Fund (EIF), the centre will bring together scientists and researc... read more…
Burnet's Malaria Researchers Among Australia's Best at Conference
4 October 2011. Australia’s best malaria researchers have come together for the two-day Malaria in Melbourne (MiM) Conference, which focuses on early-career researchers and their latest work.
?
Melbourne has more than 40 malaria labs and a lot of the world-first research into the devastating disease comes out of Melbourne-based institutes.
?
MiM is an opportunity for researchers to exp... read more…
September
Patrys Delivers Positive 10 Year Data
Melbourne, Australia; 27 September, 2011: Patrys Limited (ASX: PAB; "the Company"), today announced positive results from a follow-up of gastric cancer patients who were treated with anti-cancer compound PAT-SC1.
• Significant survival benefit for PAT-SC1 treated patients
• 10 year survival data now available
PAT-SC1 was the first of the Patrys’ IgM antibodies to be used in a clini... read more…
